
Hemo Organic Surges with Unprecedented Buying Interest, Edging Near 52-Week High
2025-12-04 10:35:31Hemo Organic Ltd has witnessed extraordinary buying momentum, with the stock hitting an upper circuit and registering only buy orders in the queue. This remarkable demand has propelled the share price close to its 52-week high, signalling a potential multi-day circuit scenario amid sustained investor enthusiasm.
Read More
Hemo Organic Surges with Unprecedented Buying Interest, Poised for Multi-Day Upper Circuit
2025-12-03 10:35:16Hemo Organic Ltd has witnessed extraordinary buying momentum, registering a 4.93% gain today while the broader Sensex declined by 0.34%. The stock’s order book reveals an unusual scenario with only buy orders queued, signalling a potential multi-day upper circuit phenomenon driven by robust investor demand.
Read More
Hemo Organic Surges with Unprecedented Buying Interest and Upper Circuit Lock
2025-12-02 10:40:29Hemo Organic Ltd has captured market attention with extraordinary buying momentum, registering a 4.92% gain today while the broader Sensex declined by 0.35%. The stock’s upper circuit lock and absence of sellers highlight a rare scenario of sustained demand, suggesting the possibility of a multi-day circuit-bound phase.
Read More
Hemo Organic Surges with Unprecedented Buying Interest and Upper Circuit Lock
2025-12-01 11:20:18Hemo Organic Ltd has witnessed extraordinary buying momentum, locking in an upper circuit with exclusively buy orders in the queue. This rare market phenomenon highlights intense demand and the potential for a sustained multi-day circuit scenario, setting the stock apart in the Trading & Distributors sector.
Read More
Hemo Organic Surges with Unprecedented Buying Interest, Poised for Multi-Day Upper Circuit
2025-11-28 10:40:16Hemo Organic Ltd has witnessed extraordinary buying momentum, registering a 4.96% gain today with only buy orders in the queue, signalling a potential multi-day upper circuit scenario. This surge stands in stark contrast to the broader market’s modest 0.23% rise, underscoring the stock’s distinct trading dynamics within the Trading & Distributors sector.
Read More
Hemo Organic Surges to Upper Circuit Amidst Unprecedented Buying Interest
2025-11-27 14:20:22Hemo Organic has witnessed extraordinary buying momentum today, hitting the upper circuit with only buy orders in the queue and no sellers present. This rare market phenomenon signals intense demand and raises the possibility of a multi-day circuit scenario, capturing the attention of traders and investors alike.
Read More
Hemo Organic Faces Intense Selling Pressure Amid Consecutive Losses
2025-11-27 12:35:21Hemo Organic Ltd has experienced a pronounced decline in market performance, marked by a day of exclusive selling activity and a sustained downward trend over the past week. The stock’s recent trading session saw a sharp fall of 4.92%, significantly underperforming the Sensex, which recorded a modest gain of 0.17%. This pattern of persistent selling pressure signals distress among investors and raises concerns about the company’s near-term outlook.
Read More
Hemo Organic’s Market Assessment Reflects Mixed Signals Amidst Flat Financials and Technical Shifts
2025-11-27 08:01:07Hemo Organic, a player in the Trading & Distributors sector, has recently undergone a revision in its market evaluation, reflecting a complex interplay of financial performance, valuation concerns, technical indicators, and overall quality metrics. This article analyses the factors influencing the current market assessment of Hemo Organic, providing investors with a comprehensive understanding of its recent performance and outlook.
Read MoreHow has been the historical performance of Hemo Organic?
2025-11-26 22:40:25Revenue and Operating Performance Trends Hemo Organic's net sales have exhibited considerable volatility over the past seven years. From a modest ₹0.05 crore in March 2019, sales dipped to near negligible levels in the subsequent years, with figures hovering around ₹0.01 crore or less until a notable surge to ₹2.41 crore in March 2025. This sharp increase in the latest fiscal year marks a significant shift in the company's top-line performance. Despite this revenue growth, the company has struggled with profitability. Operating profit before depreciation, interest, and tax (PBDIT) excluding other income remained negative for most years, reflecting operational challenges. However, the inclusion of other income in March 2025 helped push the operating profit marginally in...
Read MoreShareholder Meeting / Postal Ballot-Scrutinizers Report
09-Jan-2026 | Source : BSESubmission of scrutinizers report of Egm held on 7th January 2026 of M/s. Hemo Organics Limited
Submission Of Voting Result Of Extra Ordinary General Meeting Of M/S. Hemo Organics Limited
09-Jan-2026 | Source : BSESubmission of voting result of Extra ordinary general meeting of M/s. Hemo organics limited
Shareholder Meeting / Postal Ballot-Outcome of EGM
07-Jan-2026 | Source : BSEOutcome and Summary of EGM held today i.e. 7th January 2026
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available